MAZE THERAPEUTICS
Live / Registered — Registered (as of 13 Aug 2024)
What this means for you
Registered since 13 Aug 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88918255
- Registration number
- 7475338
- Mark type
- Stylized text
- Filed
- 15 May 2020
- Published for opposition
- 30 Mar 2021
- Registered
- 13 Aug 2024
- Attorney of record
- Joyce Liou
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating genetic diseases and disorders pharmaceutical preparations for the treatment of diseases and disorders of the metabolic system; pharmaceutical preparations for the treatment of heart diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the treatment of diabetes; reagents for medical use
Owner
- Maze Therapeutics, Inc., San Francisco, CA, US
- Maze Therapeutics, Inc., South San Francisco, CA, US
- Maze Therapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 20 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 May 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 May 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 13 Aug 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Aug 2024 — REGISTERED-PRINCIPAL REGISTER
- 08 Jul 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Jul 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Jun 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 28 May 2024 — USE AMENDMENT FILED
- 28 May 2024 — TEAS STATEMENT OF USE RECEIVED
- 01 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Oct 2023 — SOU EXTENSION 5 GRANTED
- 25 Oct 2023 — SOU EXTENSION 5 FILED